GSA Capital Partners’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$852K Sell
11,603
-10,100
-47% -$742K 0.06% 564
2025
Q1
$2.48M Sell
21,703
-20,173
-48% -$2.3M 0.22% 31
2024
Q4
$2.11M Buy
+41,876
New +$2.11M 0.16% 75
2024
Q3
Sell
-31,205
Closed -$1.01M 1646
2024
Q2
$1.01M Buy
31,205
+890
+3% +$28.9K 0.07% 490
2024
Q1
$764K Sell
30,315
-10,895
-26% -$275K 0.06% 625
2023
Q4
$1.34M Sell
41,210
-19,879
-33% -$646K 0.11% 261
2023
Q3
$1.66M Sell
61,089
-32,371
-35% -$882K 0.14% 167
2023
Q2
$2.08M Buy
93,460
+771
+0.8% +$17.2K 0.21% 53
2023
Q1
$2.01M Sell
92,689
-31,537
-25% -$683K 0.2% 69
2022
Q4
$2.52M Buy
124,226
+98,020
+374% +$1.99M 0.31% 13
2022
Q3
$672K Buy
26,206
+11,502
+78% +$295K 0.09% 364
2022
Q2
$350K Buy
14,704
+2,891
+24% +$68.8K 0.05% 725
2022
Q1
$266K Buy
+11,813
New +$266K 0.04% 982
2021
Q4
Sell
-21,154
Closed -$416K 1455
2021
Q3
$416K Buy
+21,154
New +$416K 0.04% 809
2020
Q1
Sell
-31,317
Closed -$379K 1127
2019
Q4
$379K Buy
31,317
+7,328
+31% +$88.7K 0.04% 848
2019
Q3
$339K Buy
+23,989
New +$339K 0.05% 804
2019
Q2
Sell
-43,953
Closed -$516K 1474
2019
Q1
$516K Sell
43,953
-13,198
-23% -$155K 0.05% 674
2018
Q4
$764K Buy
57,151
+33,951
+146% +$454K 0.09% 340
2018
Q3
$325K Sell
23,200
-86,182
-79% -$1.21M 0.02% 1287
2018
Q2
$1.72M Sell
109,382
-82,800
-43% -$1.3M 0.09% 358
2018
Q1
$3.16M Buy
192,182
+105,600
+122% +$1.74M 0.17% 99
2017
Q4
$1.56M Sell
86,582
-64,700
-43% -$1.17M 0.1% 336
2017
Q3
$2.92M Buy
151,282
+55,400
+58% +$1.07M 0.2% 55
2017
Q2
$1.13M Sell
95,882
-249,594
-72% -$2.94M 0.07% 475
2017
Q1
$3.79M Sell
345,476
-37,300
-10% -$409K 0.2% 58
2016
Q4
$2.78M Sell
382,776
-2,200
-0.6% -$16K 0.17% 108
2016
Q3
$2.5M Sell
384,976
-28,926
-7% -$188K 0.13% 165
2016
Q2
$2.26M Buy
413,902
+171,298
+71% +$935K 0.12% 188
2016
Q1
$1.14M Buy
242,604
+129,712
+115% +$607K 0.07% 464
2015
Q4
$562K Buy
112,892
+60,401
+115% +$301K 0.03% 1087
2015
Q3
$197K Sell
52,491
-71,000
-57% -$266K 0.01% 1582
2015
Q2
$742K Buy
+123,491
New +$742K 0.03% 1108